Načítá se...
Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination
p53 gene mutation is the most common genetic alteration in neoplastic diseases, including breast cancer, for which p53 alteration may indicate poor prognosis. Recent clinical evidence suggests that prostate-specific antigen (PSA) expression may identify breast cancer patients with favourable outcome...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
1999
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2362935/ https://ncbi.nlm.nih.gov/pubmed/10507775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6690720 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|